Literature DB >> 22026399

Comparative evaluation of the Cockcroft-Gault Equation and the Modification of Diet in Renal Disease (MDRD) study equation for drug dosing: an opinion of the Nephrology Practice and Research Network of the American College of Clinical Pharmacy.

Heather A Nyman1, Thomas C Dowling, Joanna Q Hudson, Wendy L St Peter, Melanie S Joy, Thomas D Nolin.   

Abstract

Accurate assessment of kidney function is an important component of determining appropriate drug dosing regimens. Nearly all manufacturer-recommended dosage adjustments are based on creatinine clearance ranges derived from clinical pharmacokinetic studies performed during the drug development process. The Cockcroft-Gault (CG) equation provides an estimate of creatinine clearance and is the equation most commonly used to determine drug dosages in patients with impaired kidney function. The Modification of Diet in Renal Disease (MDRD) study equation has also been proposed for this purpose. Published studies report that drug dosages determined by the two equations do not agree in 10-40% of cases. However, interpretation and comparison of these studies are complicated by the variable creatinine methods used for calculating CG and MDRD estimates, the patient populations studied, and a lack of outcomes data demonstrating the clinical significance of dosing discrepancies. Moreover, the impact of reporting standardized serum creatinine values on the accuracy of the CG equation and corresponding drug dosing regimens have been questioned. Currently, no prospective pharmacokinetic studies have been conducted with use of the MDRD equation to generate dosing recommendations, and limited data are available to support its use in some patient populations representing demographic extremes. Collectively, these issues have resulted in considerable confusion among clinicians and have fueled a healthy debate on whether or not to use the MDRD equation to determine drug dosages. Each of these issues is reviewed, and a proposed algorithm for using creatinine-based kidney function assessments in drug dosing is provided. Knowledge of the advantages, limitations, and clinical role of each equation will facilitate their safe and effective use in drug dosing.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22026399     DOI: 10.1592/phco.31.11.1130

Source DB:  PubMed          Journal:  Pharmacotherapy        ISSN: 0277-0008            Impact factor:   4.705


  26 in total

Review 1.  The applicability of eGFR equations to different populations.

Authors:  Pierre Delanaye; Christophe Mariat
Journal:  Nat Rev Nephrol       Date:  2013-07-16       Impact factor: 28.314

2.  Comparison of the Cockcroft-Gault, MDRD and CKD-EPI equations for estimating ganciclovir clearance.

Authors:  Maria-Eugenia Palacio-Lacambra; Immaculada Comas-Reixach; Albert Blanco-Grau; Josep-Maria Suñé-Negre; Alfonso Segarra-Medrano; José-Bruno Montoro-Ronsano
Journal:  Br J Clin Pharmacol       Date:  2018-07-08       Impact factor: 4.335

3.  Effectiveness of pharmacist intervention in patients with chronic kidney disease.

Authors:  Aurelio Cabello-Muriel; Juan José Gascón-Cánovas; Elena Urbieta-Sanz; Carles Iniesta-Navalón
Journal:  Int J Clin Pharm       Date:  2014-08-20

4.  Discrepancies between the Cockcroft-Gault and Chronic Kidney Disease Epidemiology (CKD-EPI) Equations: Implications for Refining Drug Dosage Adjustment Strategies.

Authors:  Pierre Delanaye; Fabrice Guerber; André Scheen; Timothy Ellam; Antoine Bouquegneau; Dorra Guergour; Christophe Mariat; Hans Pottel
Journal:  Clin Pharmacokinet       Date:  2017-02       Impact factor: 6.447

Review 5.  The use of estimated glomerular filtration rate for dose adjustment of medications in the elderly.

Authors:  Carl-Gustaf Elinder; Peter Bárány; Olof Heimbürger
Journal:  Drugs Aging       Date:  2014-07       Impact factor: 3.923

Review 6.  Methods of Estimating Kidney Function for Drug Dosing in Special Populations.

Authors:  Laura A Hart; Gail D Anderson
Journal:  Clin Pharmacokinet       Date:  2018-08       Impact factor: 6.447

Review 7.  Patient safety issues in CKD: core curriculum 2015.

Authors:  Lee-Ann Wagner; Asha L Tata; Jeffrey C Fink
Journal:  Am J Kidney Dis       Date:  2015-05-16       Impact factor: 8.860

8.  The impact of body mass index on renal functional outcomes following minimally invasive partial nephrectomy.

Authors:  Kyle A Richards; Edris Negron; Joshua A Cohn; Zoe Steinberg; Scott E Eggener; Arieh L Shalhav
Journal:  J Endourol       Date:  2014-08-21       Impact factor: 2.942

9.  Renal Drug Dosing. Effectiveness of Outpatient Pharmacist-Based vs. Prescriber-Based Clinical Decision Support Systems.

Authors:  Erin A Vogel; Sarah J Billups; Sheryl J Herner; Thomas Delate
Journal:  Appl Clin Inform       Date:  2016-07-27       Impact factor: 2.342

10.  Roles of mycobacterium tuberculosis ESAT-6 in the development of renal injury.

Authors:  Yan-Ting Gao; Li Sun; Jiang-Min Feng
Journal:  Int J Clin Exp Med       Date:  2015-11-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.